FDA issued a Warning Letter to Customceutical Compounding on 8/25/2020 as a result of this inspection.
483 Customceutical Compounding Mar 2019

483 Customceutical Compounding Mar 2019

Nicholas Hunt FDA, Christopher Jenner FDA$119.00 - Available Now

FDA investigators audited the Customceutical Compounding - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 08 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Mar 2019
  • Location: Phoenix, United States
  • FEI: 3014083318
Add To Cart
Customceutical Compounding FDA inspection 483 Mar 2019Add To Cart